ROR2 Is a Novel Prognostic Biomarker and a Potential Therapeutic Target in Leiomyosarcoma and Gastrointestinal Stromal Tumour
Journal of Pathology - United States
doi 10.1002/path.3986
Full Text
Open PDFAbstract
Available in full text
Date
February 17, 2012
Authors
Publisher
Wiley